Produced using Enzymotec’s MSO 2.0 process, K•REAL contains no trimethylamine (TMA), the volatile molecule that gives rotting fish its unpleasant smell.
It is also free from trimethylamine-oxide (TMAO), a compound found in marine products that has been linked with an increased risk of cardiovascular disease.
Scientific and popular awareness of the dangers of TMAO is rising and there is likely to be increased demand for ‘T-free’ supplements in the coming years.
Enzymotec’s TMAO-free process is patent pending, which means the company is perfectly positioned to supply its customers with krill oil that meets consumers’ needs in the future.
Tests using an in vitro stomach model have also shown K•REAL to be 5–10 times more resistant to oxidation than competitor krill products. The rate of oxidation is important because it determines the efficacy of the krill oil when it is consumed in a dietary supplement.
Avner Avissara, VP Marketing and Sales for Enzymotec’s Nutrition Division, said: “MSO 2.0 is a unique multistage oil extraction process that results in a krill oil with exceptional freshness, superb oxidation resistance and which is both T-free and may bear the low sodium claim in EU. K•REAL responds to consumer demand for dietary supplement products that are efficacious, safe and easy to use. It is produced according to USP monograph and I believe that no other krill oil delivers such a compelling package of benefits.”
K•REAL krill oil is available in wide variety of grades.
